Vertex Pharmaceuticals is a pharmaceutical company focusing on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain. Established in 1989 as a biotechnology firm, the company has dedicated itself to discovering and developing breakthrough small-molecule drugs for serious illnesses. Vertex commercializes its products both independently and in collaboration with major pharmaceutical corporations, maintaining a product pipeline concentrated on various medical conditions.
Headquartered in Boston, MA, Vertex Pharmaceuticals boasts a diverse workforce of 3,400 employees and generates an annual revenue of $8.9 billion. The company's CEO is Reshma Kewalramani M.D., leading an organization that values diversity in multiple aspects, including gender and ethnicity. Vertex offers competitive salaries to its employees, with an average salary of $95,952 per year. With great employee retention and a strong commitment to innovation, Vertex Pharmaceuticals stands as a prominent player in the pharmaceutical industry.
